Prolonged Complete Response of Early Stage Primary Adenocarcinoma of the Lung to Nivolumab Monotherapy.

Unlu, Serhan; Grant, Michael J; Gettinger, Scott; Adeniran, Adebowale; Kluger, Harriet M

Unlu, Serhan; Grant, Michael J; Gettinger, Scott; Adeniran, Adebowale; Kluger, Harriet M.

Afiliação

Unlu S; School of Medicine, Koc University, Istanbul, Turkey.
Grant MJ; Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Gettinger S; Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Adeniran A; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Kluger HM; Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.

Clin Oncol Case Rep ; 4(1)2021 Jan.

Article em En | MEDLINE | ID: mdl-34382032

Palavras-chave

Immune checkpoint inhibitor; Lung cancer; Malignant tumor; Melanoma; Primary lesion; Therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Oncol Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google